A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Mumps
Related studies linked through entity extraction aliases.
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children
- Status
- COMPLETED
- Phase
- PHASE3
Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
- Status
- COMPLETED
- Phase
- N/A
Making Decisions About the Measles-Mumps-Rubella Vaccine
- Status
- COMPLETED
- Phase
- NA
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
- Status
- COMPLETED
- Phase
- PHASE3
ProQuad Dose Selection Study (V221-011)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines
- Status
- COMPLETED
- Phase
- PHASE3
ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
- Status
- COMPLETED
- Phase
- PHASE3
Measles, Mumps, and Rubella (MMR) Immunity in College Students
- Status
- COMPLETED
- Phase
- N/A
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
- Status
- UNKNOWN
- Phase
- N/A
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ProQuad™ in Healthy Children in Korea (V221-023)
- Status
- TERMINATED
- Phase
- PHASE3
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
- Status
- COMPLETED
- Phase
- PHASE3